HONG KONG , Dec. 4, 2024 /PRNewswire/ -- Dunxin Financial Holdings Limited ("Dunxin" or the "Company") (OTC Pink: DXFFY), a company engaged in real estate operation management and investment and a digital technology security business in Hong Kong , today announced that it plans to change the ratio of its American depositary shares ("ADSs") from one (1) ADS representing four hundred and eighty (480) Class A ordinary shares to one (1) ADS representing sixty thousand (60,000) Class A ordinary shares. The effect of the ratio change on the ADS trading price on the OTC Pink (the "OTC") is expected to take place at the open of trading on December 4, 2024 (U.S. Eastern Time). For the Company's ADS holders, the ADS ratio change will have the same effect as a one-for-one hundred and twenty-five reverse split. There will be no change to the Company's Class A ordinary shares. ADS holders of record on the effective date will need to surrender their ADS to the depositary bank for cancellation and exchange in connection with the ADS ratio change, with further details to be provided in the notice by the depositary bank. As of the effective date for the ADS ratio change, Dunxin's ADSs will continue to be traded on the OTC under the symbol "DXFFY". No fractional new ADSs will be issued in connection with the change in the ADS ratio. Instead, fractional entitlements to new ADSs will be aggregated and sold by the depositary bank and the net cash proceeds from the sale of the fractional ADS entitlements (after deduction of fees, taxes and expenses) will be distributed to the applicable ADS holders by the depositary bank. As a result of the change in the ADS ratio, the ADS price is expected to increase proportionally, although the Company can give no assurance that the ADS price after the change in the ADS ratio will be equal to or greater than the ADS price on a proportionate basis. About Dunxin Financial Holdings Limited Dunxin is a licensed microfinance lender serving individuals and SMEs in Hubei Province , China . Dunxin suspended offering loans to its customers since 2020. Safe Harbor Statement This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of market in China and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov . The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
Enerpac Tool Group Schedules First Quarter Fiscal 2025 Earnings Release and Conference CallPLC Software Market to Grow by USD 853.2 Million (2024-2028), Driven by Industrial Automation and Digitization, Report Highlights AI-Powered Market Evolution - Technavio
Job Cuts Spike, Marking 4th-Worst November Since 2008–09 Financial Crisis
Abrdn Income Credit Strategies Fund 5.25% Series A Perpetual Preferred Shares Declare Quarterly DividendBitcoin Depot Continues Mission of Bringing Bitcoin to the Masses as Bitcoin Surges Past ...
Sportsman's Warehouse Holdings, Inc. Announces Third Quarter 2024 Financial Results
DAT: November truckload volumes lagged robust OctoberBecton Dickinson & Co. stock underperforms Tuesday when compared to competitors
JFrog director Sela Yossi sells $782,250 in stock
DETROIT (AP) — In the waning days of President Joe Biden's administration, the government's highway safety agency is proposing voluntary safety guidelines for self-driving vehicles. But a rule from the National Highway Traffic Safety Administration putting the plan in place won't be approved before the end of Biden's term in January and likely will be left to whoever runs the agency under Republican Donald Trump. Tesla CEO Elon Musk, whom Trump has named to co-lead a “Department of Government Efficiency” to cut costs and regulations, has floated the idea of him helping to develop safety standards for self-driving vehicles — even though the standards would affect Tesla's automated driving systems. At present there are no federal regulations that specifically govern autonomous vehicles, and any regulation is left to states. However, self-driving vehicles must meet broad federal safety standards that cover all passenger vehicles. Under the agency's proposal, released on Friday, automakers and autonomous vehicle companies could enroll in a program that would require safety plans and some data reporting for autonomous vehicles operating on public roads. To apply companies would have to have independent assessments of their automated vehicle safety processes, and there would be requirements to report crashes and other problems with the vehicles. Companies would have to give NHTSA information and data on the safety of the design, development and operations of the vehicles. The agency would decide whether to accept companies into the program. But auto safety advocates say the plan falls short of needed regulation for self-driving vehicles. For instance, it doesn't set specific performance standards set for the vehicles such as numbers and types of of sensors or whether the vehicles can see objects in low-visibility conditions, they said. “This is a big bunch of nothing,” said Missy Cummings, director of the autonomy and robotics center at George Mason University and a former safety adviser to NHTSA. “It’ll be more of a completely useless paperwork drill where the companies swear they’re doing the right thing.” Michael Brooks, executive director of the nonprofit Center for Auto Safety, said one of the few good things about the plan is that companies will have to report data on crashes and other problems. There have been reports that the Trump administration may want to scrap a NHTSA order that now requires autonomous vehicle companies to report crashes to the agency so it can collect data. A message was left Friday seeking comment from the Trump transition team on crash reporting requirements. Brooks said the incoming administration probably will want to put out its own version of the guidelines. NHTSA will seek public comment on the plan for about 60 days, then the plan would have to wind its way through the federal regulatory process, which can take months or even years. “It is important that ADS (Automated Driving System) technology be deployed in a manner that protects the public from unreasonable safety risk while at the same time allowing for responsible development of this technology, which has the potential to advance safety,” the proposed rule says. The agency concedes that in the future, there may be a need for NHTSA to set minimum standards for self driving vehicle performance that are similar to mandatory safety standards that govern human-driven cars. But the agency says it now doesn't have data and metrics to support those standards. The voluntary plan would help gather those, the proposal said.
England [UK], December 20 (ANI): Artificial intelligence can provide important insights into how complex chemical mixes in rivers affect aquatic life, paving the path for more effective environmental protection. A novel methodology developed by academics at the University of Birmingham shows how advanced artificial intelligence (AI) approaches can assist in discovering potentially dangerous chemical chemicals in rivers by monitoring their impacts on small water fleas (Daphnia). The team worked with scientists at the Research Centre for Eco-Environmental Sciences (RCEES), in China, and the Helmholtz Centre for Environmental Research (UFZ), in Germany, to analyse water samples from the Chaobai River system near Beijing. This river system receives chemical pollutants from a number of different sources, including agricultural, domestic and industrial. Professor John Colbourne is the director of the University of Birmingham’s Centre for Environmental Research and Justice and one of the senior authors on the paper. He expressed optimism that, by building upon these early findings, such technology can one day be deployed to routinely monitor water for toxic substances that would otherwise be undetected. He said: “There is a vast array of chemicals in the environment. Water safety cannot be assessed one substance at a time. Now we have the means to monitor the totality of chemicals in sampled water from the environment to uncover what unknown substances act together to produce toxicity to animals, including humans.” The results, published in Environmental Science and Technology, reveal that certain mixtures of chemicals can work together to affect important biological processes in aquatic organisms, which are measured by their genes. The combinations of these chemicals create environmental hazards that are potentially greater than when chemicals are present individually. The research team used water fleas (Daphnia) as test organisms in the study because these tiny crustaceans are highly sensitive to water quality changes and share many genes with other species, making them excellent indicators of potential environmental hazards. “Our innovative approach leverages Daphnia as the sentinel species to uncover potential toxic substances in the environment,” explains Dr Xiaojing Li, of the University of Birmingham (UoB) and the lead author of this study. “By using AI methods, we can identify which subsets of chemicals might be particularly harmful to aquatic life, even at low concentrations that wouldn’t normally raise concerns.” Dr Jiarui Zhou, also at the University of Birmingham and co-first author of the paper, who led the development of the AI algorithms, said: “Our approach demonstrates how advanced computational methods can help solve pressing environmental challenges. By analysing vast amounts of biological and chemical data simultaneously, we can better understand and predict environmental risks.” Professor Luisa Orsini, another senior author of the study, added: “The study’s key innovation lies in our data-driven, unbiased approach to uncovering how environmentally relevant concentrations of chemical mixtures can cause harm. This challenges conventional ecotoxicology and paves the way to regulatory adoption of the sentinel species Daphnia, alongside new approach methodologies.” Dr Timothy Williams of the University of Birmingham and co-author of the paper also noted that: “Typically, aquatic toxicology studies either use a high concentration of an individual chemical to determine detailed biological responses or only determine apical effects like mortality and altered reproduction after exposure to an environmental sample. However, this study breaks new ground by allowing us to identify key classes of chemicals that affect living organisms within a genuine environmental mixture at relatively low concentration while simultaneously characterising the biomolecular changes elicited.” (ANI) This report is auto-generated from ANI news service. ThePrint holds no responsibility for its content. var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );Prudential Financial names insider Andrew Sullivan as CEODonald Trump is returning to the world stage. So is his trollingNEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ASP Isotopes Inc. (NASDAQ: ASPI) between October 30, 2024 and November 26, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased ASP Isotopes securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the ASP Isotopes class action, go to https://rosenlegal.com/submit-form/?case_id=32062 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 3, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) ASP Isotopes overstated the potential effectiveness of its enrichment technology; (2) ASP Isotopes overstated the development potential of its high assay low-enriched uranium facility; (3) ASP Isotopes overstated ASP Isotopes’ nuclear fuels operating segment results; and (4) as a result of the foregoing, defendants’ positive statements about ASP Isotopes’ business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the ASP Isotopes class action, go to https://rosenlegal.com/submit-form/?case_id=32062 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com
B.C. premier says feds and premiers have right-left strategy to tackle Trump tariffsNone
Softgel Capsules Market Set for Exceptional Growth in the Forecast 2024-2032 12-20-2024 06:51 PM CET | Health & Medicine Press release from: Cognate Insights Softgel Capsules Market Latest Market Overview The global softgel capsules market is projected to experience significant growth, with a market size of USD 11.3 billion in 2024, expected to reach USD 20.2 billion by 2032, growing at a CAGR of 7.5% during the forecast period. Softgel capsules have gained prominence as a preferred dosage form due to their ease of ingestion, enhanced bioavailability, and versatility in encapsulating a wide range of ingredients. The increasing demand for dietary supplements, pharmaceuticals, and nutraceuticals is a major factor driving the market's expansion. The Softgel Capsules Market has experienced steady growth in recent years and is expected to continue expanding at a strong pace from 2024 to 2032. This analysis offers a comprehensive overview, providing valuable insights into key trends and developments within the Softgel Capsules industry. These findings equip business leaders with the necessary knowledge to devise more effective strategies and enhance profitability. Furthermore, the report serves as a useful resource for new and emerging businesses, helping them make informed decisions as they navigate the market and seek growth opportunities. Major Players of Softgel Capsules Market are: Catalent, Inc. - U.S. | Revenue: $4.83 billion (2023) Aenova Group - Germany | Revenue: $865 million (2023) Capsugel (Lonza Group) - Switzerland | Revenue: $6.21 billion (2023) Sirio Pharma Co., Ltd. - China | Revenue: $524 million (2023) Soft Gel Technologies, Inc. - U.S. | Revenue: $215 million (2023) Amway - U.S. | Revenue: $8.1 billion (2023) Get Latest PDF Sample Report @ https://www.cognateinsights.com/request-sample/softgel-capsules-market-research Our Report covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2032 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets. Global Softgel Capsules Market Landscape and Future Pathways: North America: United States Canada Europe: Germany France U.K. Italy Russia Asia-Pacific: China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America: Mexico Brazil Argentina Korea Colombia Middle East & Africa: Turkey Saudi Arabia UAE Korea Speak to Our Analyst for A Discussion on The Above Findings, And Ask for A Discount on The Report @ https://www.cognateinsights.com/check-discount/softgel-capsules-market-research Key drivers and challenges influencing the Softgel Capsules market: Regional Analysis: The report involves examining the Softgel Capsules market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets. Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Softgel Capsules market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends. Company Analysis: Report covers individual Softgel Capsules manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies. Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Softgel Capsules This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application. Technology Analysis: Report covers specific technologies relevant to Softgel Capsules. It assesses the current state, advancements, and potential future developments in Softgel Capsules areas. Reason to Buy this Report: -Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years. -Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants. -Overview of the competitive landscape in the Softgel Capsules market, including profiles of the key players, their market share, and strategies for growth. -Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth. -Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants. For In-Depth Competitive Analysis - Purchase this Report now at @ https://www.cognateinsights.com/purchase-report/softgel-capsules-market-research Contact Us: Cognate Insights Web: www.cognateinsights.com Email: info@cognateinsights.com Phone: +91 8424946476 About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.AI can reveals hidden hazards of chemical mixtures in rivers: Study